Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Share News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
234.50    0.00 (0.00%)
Bid:
232.50
Ask:
234.50
Spread: 2.00 (0.86%)
Market Cap: £136.80m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

MJGleeson News

MJ Gleeson expects annual results "significantly" ahead of forecasts
11 Jul 2022

MJ Gleeson expects annual results "significantly" ahead of forecasts

(Alliance News) - Shares in MJ Gleeson PLC rose on Monday after it reported higher house selling prices and said its full-year results will be "signif...

MJ Gleeson ends year 'significantly ahead' of expectations
11 Jul 2022

MJ Gleeson ends year 'significantly ahead' of expectations

(Sharecast News) - Low-cost housebuilder MJ Gleeson said in a trading update on Monday that its Gleeson Homes division achieved its medium-term goal o...

"Mixed" surveys and cladding worries hitting housebuilding shares
7 Jul 2022

"Mixed" surveys and cladding worries hitting housebuilding shares

(Alliance News) - A warning from Persimmon PLC on lower half-year revenue and completions did little to put the UK housebuilding sector back in favou...

SMALL-CAP WINNERS & LOSERS: Kenmare up on bullish note; Hunting rises
7 Jul 2022

SMALL-CAP WINNERS & LOSERS: Kenmare up on bullish note; Hunting rises

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Thursday.

SMALL-CAP WINNERS & LOSERS: Oxford BioMedica rises on AstraZeneca deal
1 Jul 2022

SMALL-CAP WINNERS & LOSERS: Oxford BioMedica rises on AstraZeneca deal

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Friday.

IN BRIEF: MJ Gleeson hits medium-term target of doubling home sales
1 Jul 2022

IN BRIEF: MJ Gleeson hits medium-term target of doubling home sales

MJ Gleeson PLC - Sheffield-based housebuilder and land investor - Says it completed its medium-term target of doubling house sales. It completed the s...

LONDON MARKET PRE-OPEN: Oxford Biomedica inks new AstraZeneca jab deal
1 Jul 2022

LONDON MARKET PRE-OPEN: Oxford Biomedica inks new AstraZeneca jab deal

(Alliance News) - Stock prices in London are seen opening lower on Friday following another sell-off on Wall Street fuelled by recession fears, while ...